We are live on ! Find out more
BI

BVF Inc Portfolio holdings

AUM $3.14B
1-Year Est. Return 249.53%
This Fund
S&P 500
This Quarter Est. Return
-2.94%
1 Year Est. Return
+249.53%
3 Year Est. Return
+690.11%
5 Year Est. Return
+1,011.36%
10 Year Est. Return
+22,702.25%
AUM
$2.56B
AUM Growth
-$105M
Cap. Flow
+$128M
Cap. Flow %
4.99%
Top 10 Hldgs %
48.1%
Holding
79
New
9
Increased
20
Reduced
11
Closed
4

Top Buys

Rank Stock Value
1
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$66.5M
2
AMRN
Amarin Corp
AMRN
+$47.6M
3
WHWK
Whitehawk Therapeutics
WHWK
+$35M
4
TYRA icon
Tyra Biosciences
TYRA
+$32.4M
5
KYMR icon
Kymera Therapeutics
KYMR
+$31.9M

Top Sells

Rank Stock Value
1
MRUS
Merus
MRUS
+$156M
2
ARGX icon
argenx
ARGX
+$90.3M
3
RLAY icon
Relay Therapeutics
RLAY
+$29.9M
4
FBRX icon
Forte Biosciences
FBRX
+$19.9M
5
IMVT icon
Immunovant
IMVT
+$13.5M

Sector Composition

Rank Sector Weight
1 Healthcare 94.03%
2 Financials 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTA
76
DELISTED
Centessa Pharmaceuticals
CNTA
– –
-58,900
Closed -$1.31M
FBRX icon
77
Forte Biosciences
FBRX
$1.57B
– –
-23,672
Closed -$19.9M
IMVT icon
78
Immunovant
IMVT
$7.85B
– –
-1,273,516
Closed -$13.5M
MRUS
79
DELISTED
Merus
MRUS
– –
-7,285,071
Closed -$156M
1 2 3
4

Similar funds

GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return

BVF Inc's Q3 2021 Portfolio in Review

As of Q3 2021, BVF Inc held 79 positions worth $2.56B, down 3.9% from $2.67B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

BVF Inc deployed $128M of net new capital in Q3 2021, opening 9 new positions and adding to 20 existing holdings. Its largest new stake was Lakefront Biotherapeutics American Depositary Shares: 1,119,733 shares worth $58.9M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 98% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was argenx, an estimated $90.3M trimmed.

  • BVF Inc's largest Q3 2021 buy was Lakefront Biotherapeutics American Depositary Shares: 1,119,733 shares worth $58.9M.
  • BVF Inc added most to Amarin Corp in Q3 2021, an estimated $47.6M increase.
  • BVF Inc's biggest Q3 2021 reduction was argenx, cutting an estimated $90.3M.
  • BVF Inc fully exited Merus in Q3 2021, selling an estimated $156M.
  • BVF Inc's ten largest holdings make up 48% of its $2.56B portfolio in Q3 2021.
  • BVF Inc opened 9 new positions and closed 4 in Q3 2021.
  • BVF Inc's portfolio value fell 3.9% quarter-over-quarter to $2.56B.

Based on BVF Inc's 13F filing for Q3 2021, filed 15 Nov 2021.